Back

sGLTII inhibitors for heart failure .

1 September 2019 (17:32 - 17:50)
Organised by:
Congress Presentation Part of: Success stories in translation from bench to bedside Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Gary D Lopaschuk

University of Alberta, Edmonton (Canada)

3 More presentations in this session

Presentation thumbnail
PCSK9 inhibition for cholesterol lowering.
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
Prolactin for peripartum cardiomyopathy.
Professor D. Hilfiker-Kleiner (Hannover, DE)
Presentation thumbnail
Tafamidis for cardiac amyloidosis.
Professor C. Rapezzi (Ferrara, IT)
Slides Video

Access the full session

Session thumbnail
Success stories in translation from bench to bedside

The Event

Event poster

ESC Congress 2019

1 September 2019 17:32 CET
You may be interested in
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
30 August 2024
thumbnail
Congress Presentation
Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence
29 June 2021
thumbnail
Congress Presentation
SGLT2 Inhibitors in patients with cancers
20 June 2025
thumbnail
Congress Presentation
Eligibility and prescribing rates of SGLT2 inhibitors for patients with heart failure from a large tertiary centre
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources